comparemela.com

Page 15 - Sriparna Roy News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UnitedHealth says hack could impact data of substantial proportion of Americans

(Reuters) -UnitedHealth Group said on Monday that hackers stole health and personal data of potentially a "substantial proportion" of Americans from its systems in February, as the largest U.S. health insurer scrambles to contain the damage. The intrusion at its Change Healthcare unit, which processes about 50% of U.S. medical claims, was one of the worst hacks to hit American healthcare and caused widespread disruption in payment to doctors and health facilities. The disclosure suggests patients' healthcare information remains vulnerable.

UnitedHealth says hack could impact data of substantial proportion of Americans

(Reuters) -UnitedHealth Group said on Monday that hackers stole health and personal data of potentially a "substantial proportion" of Americans from its systems in February, as the largest U.S. health insurer scrambles to contain the damage. The intrusion at its Change Healthcare unit, which processes about 50% of U.S. medical claims, was one of the worst hacks to hit American healthcare and caused widespread disruption in payment to doctors and health facilities. The disclosure suggests patient

UnitedHealth says hack could impact data of substantial proportion of Americans

UnitedHealth says hack could impact data of substantial proportion of Americans
yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.

Cerevel Therapeutics Parkinson s disease drug meets main goal in late-stage study | WKZO | Everything Kalamazoo

(Reuters) -Cerevel Therapeutics said on Thursday its Parkinson's disease drug met the main goal of a late-stage trial. The trial was testing the drug tavapadon as an add-on therapy to levadopa, the standard of care for Parkinson's disease. The results .

Johnson & Johnson to buy Shockwave Medical for $12 5 billion

The acquisition gives J&J access to a device that uses shockwaves to break down calcified plaque in heart vessels, similar to how kidney stones are treated. The conglomerate is focusing on building its cardiac health business and spent $16.6 billion to buy heart pump maker Abiomed in 2022 and $400 million to buy another heart-centric device maker Laminar. Shockwave's catheter-based treatment known as intravascular lithotripsy (IVL) is used, often in combination with stents, to treat two heart conditions in which arteries get clogged with calcium deposits.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.